Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Import Basics

Import Basics

                        FDA’s Administrative Destruction Authority
          Overview of the SUPPORT Act Provisions Related to Imports
          Common Entry Types
          Foreign Trade Zones/Weekly Entry Filing
          International Mail Facilities
          Personal Importation
          Import for Export
          Harmonized Tariff Schedule and FD Flags


                        Import Systems Home
          For Industry
          Import Program – Food and Drug Administration (FDA)
          Import Basics
          Overview of the SUPPORT Act Provisions Related to ImportsImport Basics Overview of the SUPPORT Act Provisions Related to Imports
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe SUPPORT (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment [SUPPORT] for Patients and Communities) Act was enacted on October 24, 2018. This new law grants FDA additional import authorities that FDA believes will meaningfully advance efforts to stop illegal and unsafe drugs from being imported into the United States. For example, the SUPPORT Act includes:

Improvements to the infrastructure and resources of International Mail Facilities (IMFs);
	Authority to treat an FDA-regulated article as a drug if that article contains an active ingredient that is found in an FDA-approved drug or licensed biologic, and the ingredient presents a significant public health concern;
	Authority for FDA to debar people who have been convicted of a felony involving illegal importation of drugs or controlled substances, or who have engaged in a pattern of illegally importing controlled substances or certain adulterated or misbranded drugs; and
	Authority for FDA to treat any imported drugs as illegal from a person who has engaged in a pattern of importing adulterated or misbranded drugs if the shipments are from the same manufacturer, distributor, or importer.The following is an overview of certain key import-related provisions of the SUPPORT Act:

**Improved Operations at International Mail Facilities**

Section 3014 of the SUPPORT Act will enhance FDA’s ability to efficiently and effectively detect and stop illegal and unsafe drug imports from entering the United States via international mail. It does this by providing for improvements of IMF facilities and processes, including facility upgrades or renovations, improvements in equipment and information technology, increased laboratory capacity, and security upgrades.

Under section 3022(a) of the SUPPORT Act, FDA and U.S. Customs and Border Protection (CBP) will develop a mutually agreed-upon list of controlled substances that FDA will refer to CBP for disposition under the Controlled Substances Act when such substances have been identified in international mail parcels. The list will be reviewed and updated periodically to remain current and relevant.

**Articles Containing API(s) Can be Treated as Drugs**

Section 3022(d) of the SUPPORT Act amends section 801 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) to give FDA authority to treat an FDA-regulated article as a drug if that article contains at least one of three items:

An active pharmaceutical ingredient (API) that is found in an FDA-approved drug or licensed biologic;
	An API in a drug or biologic that has been granted an investigational-use exemption and for which a substantial clinical investigation has been instituted and made public; or
	An analog of that active ingredient.In addition, the ingredient must present a significant public health concern.  FDA is currently implementing this authority for articles offered for import via international mail.

For an overview of human drugs and the requirements that FDA verifies at the time they are imported or offered for import into the United States, please visit Human Drugs – General.

**Debarment from Importing Drugs**

Section 3022(b) of the SUPPORT Act amends section 306(b) of the FD&C Act to give FDA authority to debar a person who has been convicted of a felony involving illegal importation of drugs or controlled substances, or who has engaged in a pattern of importing certain adulterated or misbranded drugs or controlled substances. Once debarred, that person is prohibited from being involved in any future drug importation for up to five years. Violation of a debarment order is a criminal offense.

**Multiple Shipments of Drugs Can Be Treated as Adulterated or Misbranded**



Section 3013 of the SUPPORT Act amends section 801 of the FD&C Act to give FDA authority to treat as illegal any shipments of drugs from a person whom FDA has determined is engaging in a pattern of illegally importing adulterated or misbranded drugs from the same manufacturer, distributor, or importer.

                                                                                  Content current as of:
      11/17/2020Import Basics

          
                        FDA’s Administrative Destruction Authority
          Overview of the SUPPORT Act Provisions Related to Imports
          Common Entry Types
          Foreign Trade Zones/Weekly Entry Filing
          International Mail Facilities
          Personal Importation
          Import for Export
          Harmonized Tariff Schedule and FD Flags


                        Import Systems
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop